Senior insider sale
SUPERNUS PHARMACEUTICALS, INC. — senior position signals high conviction
$269.5K
6K shares
What this filing means
NEWHALL CHARLES W III plans to sell 6K shares of SUPERNUS PHARMACEUTICALS, INC. valued at approximately $269.5K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/25/2025ACC: 0001950047-25-006350
Director
Since Feb 2026
6K
Shares to sell
$269.5K
Approx. market value
4.59K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
In-Kind Distribution
N/A
5/1/2012
4.59KTotal acquired4.59K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/1/2012 | In-Kind Distribution N/A | 4.59K | — |
| Total | 4.59K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
1.41K
Market value
$63.5K
8/22/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
4.59K
Market value
$205.9K
8/25/2025
Total
Units
6K
Value
$269.5K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
8/22/2025 | 1.41K | $63.5K | — | Completed |
| Planned — Approximate Date | ||||
8/25/2025 | 4.59K | $205.9K | NASDAQ | Planned |
| Total | 6K | $269.5K | ||